The ROE as of July 2025 (TTM) for GreenLight Biosciences Holdings (GRNA) is -1847.24%

According to GreenLight Biosciences Holdings’s latest financial reports and current stock price. The company's current ROE is -1847.24%. This represents a change of 1.06% compared to the average of -158.58% of the last 4 quarters.

GreenLight Biosciences Holdings (GRNA) Historical ROE (quarterly & annually)

How has GRNA ROE performed in the past?

The mean historical ROE of GreenLight Biosciences Holdings over the last ten years is 26.93%. The current -1847.24% ROE has changed -6960.35% with respect to the historical average. Over the past ten years (40 quarters), GRNA's ROE was at its highest in in the December 2021 quarter at 34.89%. The ROE was at its lowest in in the June 2021 quarter at -543.48%.

GreenLight Biosciences Holdings (GRNA) ROE by Quarter and Year

Discovering the peaks and valleys of GreenLight Biosciences Holdings ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GreenLight Biosciences Holdings (GRNA) Average ROE

How has GRNA ROE performed in the past?

The current ROE of GreenLight Biosciences Holdings (GRNA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

GreenLight Biosciences Holdings (GRNA) ROE vs. Peers

How is GRNA’s ROE compared to its peers?

GreenLight Biosciences Holdings’s ROE is greater than Lexaria Bioscience Corp. (-107.00%), less than Navidea Biopharmaceuticals, Inc. (355.34%), greater than ZyVersa Therapeutics, Inc. (-111.93%), greater than Biodexa Pharmaceuticals Plc (-38.81%), greater than Oncorus, Inc. (-82.19%), greater than Senti Biosciences, Inc. (-177.25%), less than ZIVO Bioscience, Inc. (1.00%), greater than Cadrenal Therapeutics, Inc. Common Stock (-171.55%), less than Foghorn Therapeutics Inc. (214.80%), less than Quoin Pharmaceuticals, Ltd. (-0.45%), greater than Nutriband Inc. (-113.25%), greater than Longeveron Inc. (-85.06%), greater than RenovoRx, Inc. (-119.58%), greater than Virax Biolabs Group Limited (-91.77%), greater than Blue Water Vaccines, Inc. (-293.56%), greater than PaxMedica, Inc. Common Stock (-1367.11%), greater than Revelation Biosciences, Inc. (-505.44%), greater than Hillstream BioPharma, Inc. (-550.15%),

Build a custom stock screener for GreenLight Biosciences Holdings (GRNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GreenLight Biosciences Holdings using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GreenLight Biosciences Holdings (GRNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GreenLight Biosciences Holdings or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.